Grown Rogue International (GRUSF) Other Accumulated Expenses (2018 - 2021)
Grown Rogue International (GRUSF) posted quarterly Other Accumulated Expenses of $125000.0 for Q1 2021, up 2333.8% quarter-over-quarter from $5136.0 in Q3 2019.
Grown Rogue International (GRUSF) Other Accumulated Expenses (2018 - 2021) Analysis & Trends
Grown Rogue International's Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $125000.0 for Q1 2021.
- In Q1 2021, Other Accumulated Expenses changed N/A year-over-year to $125000.0; the TTM figure through Jan 2021 stood at $125000.0 (changed N/A YoY), while the FY2018 annual figure was $720516.0, changed N/A from the prior year.
- Other Accumulated Expenses for Q1 2021 stood at $125000.0, up from $5136.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $720516.0 in Q4 2018, with the low at $5136.0 in Q2 2019.
- The 3-year median for Other Accumulated Expenses is $85136.0 (2019), against an average of $188184.8.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Grown Rogue International | 116.22 Mn | 104.68 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 125,000.00 |
| Jul 31, 2019 | 5,136.00 |
| Apr 30, 2019 | 5,136.00 |
| Jan 31, 2019 | 85,136.00 |
| Oct 31, 2018 | 720,516.00 |